ASNS

Chr 7

asparagine synthetase (glutamine-hydrolyzing)

Also known as: ASNSD, TS11

The protein encoded by this gene is involved in the synthesis of asparagine. This gene complements a mutation in the temperature-sensitive hamster mutant ts11, which blocks progression through the G1 phase of the cell cycle at nonpermissive temperature. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2010]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.74
Clinical SummaryASNS
🧬
Gene-Disease Validity (ClinGen)
congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
171 unique Pathogenic / Likely Pathogenic· 233 VUS of 845 total submissions
📖
GeneReview available — ASNS
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.74LOEUF
pLI 0.000
Z-score 2.62
OE 0.47 (0.300.74)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.86Z-score
OE missense 0.70 (0.630.79)
220 obs / 312.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.47 (0.300.74)
00.351.4
Missense OE?0.70 (0.630.79)
00.61.4
Synonymous OE?0.88
01.21.6
LoF obs/exp: 13 / 27.9Missense obs/exp: 220 / 312.4Syn Z: 1.02
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveASNS-related asparagine synthetase deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7327th %ile
GOF
0.6736th %ile
LOF
0.2970th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

845 submitted variants in ClinVar

Classification Summary

Pathogenic72
Likely Pathogenic99
VUS233
Likely Benign381
Benign27
Conflicting24
72
Pathogenic
99
Likely Pathogenic
233
VUS
381
Likely Benign
27
Benign
24
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
63
5
4
0
72
Likely Pathogenic
73
24
2
0
99
VUS
2
206
19
6
233
Likely Benign
1
4
152
224
381
Benign
0
1
24
2
27
Conflicting
24
Total139240201232836

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

15 pathogenic / likely-pathogenic (of 20) ClinVar copy-number / structural variants overlap ASNS — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ASNS · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →